FI921809A0 - Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur. - Google Patents

Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur.

Info

Publication number
FI921809A0
FI921809A0 FI921809A FI921809A FI921809A0 FI 921809 A0 FI921809 A0 FI 921809A0 FI 921809 A FI921809 A FI 921809A FI 921809 A FI921809 A FI 921809A FI 921809 A0 FI921809 A0 FI 921809A0
Authority
FI
Finland
Prior art keywords
foer
pct
monoklinisk
fuktighetkaenslig
dragekomposition
Prior art date
Application number
FI921809A
Other languages
English (en)
Other versions
FI103015B1 (fi
FI103015B (fi
FI921809A (fi
Inventor
Istvan Kovacs
Katalin Beke
Tibor Mate
Judit Szilagyi
Gyoergy Bacsa
Katalin Marossy
Sandor Jancso
Levente Szendrei
Erno Orban
Margit Simo
Margit Biblo
Dorottya Bobak
Jozsef Lango
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of FI921809A0 publication Critical patent/FI921809A0/fi
Publication of FI921809A publication Critical patent/FI921809A/fi
Application granted granted Critical
Publication of FI103015B1 publication Critical patent/FI103015B1/fi
Publication of FI103015B publication Critical patent/FI103015B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Press Drives And Press Lines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI921809A 1990-08-24 1992-04-23 Menetelmä tabletti- tai raekoostumuksen valmistamiseksi, joka sisältää lämmölle, valolle ja kosteudelle herkkää aktiivista aineosaa, jolla o n monokliininen kiderakenne FI103015B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU531490 1990-08-24
HU905314A HU206824B (en) 1990-08-24 1990-08-24 Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
HU9100039 1991-08-23
PCT/HU1991/000039 WO1992003126A1 (en) 1990-08-24 1991-08-23 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure

Publications (4)

Publication Number Publication Date
FI921809A0 true FI921809A0 (fi) 1992-04-23
FI921809A FI921809A (fi) 1992-04-23
FI103015B1 FI103015B1 (fi) 1999-04-15
FI103015B FI103015B (fi) 1999-04-15

Family

ID=10970061

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921809A FI103015B (fi) 1990-08-24 1992-04-23 Menetelmä tabletti- tai raekoostumuksen valmistamiseksi, joka sisältää lämmölle, valolle ja kosteudelle herkkää aktiivista aineosaa, jolla o n monokliininen kiderakenne

Country Status (19)

Country Link
US (1) US5322698A (fi)
EP (1) EP0500851B1 (fi)
JP (1) JPH0813736B2 (fi)
KR (1) KR0177493B1 (fi)
AT (1) ATE119388T1 (fi)
CA (1) CA2067733C (fi)
CZ (1) CZ281577B6 (fi)
DE (1) DE69108007T2 (fi)
DK (1) DK0500851T3 (fi)
ES (1) ES2072617T3 (fi)
FI (1) FI103015B (fi)
GR (1) GR3015719T3 (fi)
HU (1) HU206824B (fi)
IL (1) IL99237A (fi)
IN (1) IN171740B (fi)
NO (1) NO303669B1 (fi)
PT (1) PT98758B (fi)
SK (1) SK278919B6 (fi)
WO (1) WO1992003126A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
ATE241341T1 (de) * 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd Stabilisierte pharmazeutische zusammensetzung
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
AU769807B2 (en) * 1999-08-04 2004-02-05 Astellas Pharma Inc. Stable medicinal compositions for oral use
WO2002011740A2 (en) 2000-08-10 2002-02-14 Unihart Corporation 'slow release' pharmaceutical compositions comprising lithium carbonate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907999A (en) * 1968-01-30 1975-09-23 Merck & Co Inc Substituted dibenzocyclooctene compositions
NL167153C (nl) * 1968-12-24 1981-11-16 Merck & Co Inc Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat en werkwijze voor het bereiden van een farmacologisch werkzaam, aan het stikstofatoom gesubstitueerd 5-aminomethyl-5-hydroxy-5h-dibenzoÿa.dÿ- cyclohepteen, geschikt voor gebruik bij de genoemde werkwijze.
DE2416903A1 (de) * 1974-04-06 1975-10-09 Bayer Ag Verwendung von schmelzverspruehtem kugelfoermigem phenacetingranulat zur herstellung von tabletten im direkttablettierverfahren
US4198402A (en) * 1975-12-17 1980-04-15 Richter Gedeon Vegyeszeti Gyar Rt. Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment
EP0112061A3 (en) * 1982-11-20 1985-08-14 Beecham Group Plc Pharmaceutical or veterinary compositions containing guanoxabenz
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
CA1261261A (en) * 1985-03-08 1989-09-26 Dev K. Mehra Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4707361A (en) * 1985-08-02 1987-11-17 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting

Also Published As

Publication number Publication date
NO921569L (no) 1992-04-23
JPH05503540A (ja) 1993-06-10
WO1992003126A1 (en) 1992-03-05
GR3015719T3 (en) 1995-07-31
JPH0813736B2 (ja) 1996-02-14
PT98758B (pt) 1999-01-29
HU206824B (en) 1993-01-28
DK0500851T3 (da) 1995-07-24
DE69108007T2 (de) 1995-07-20
IL99237A0 (en) 1992-07-15
HU905314D0 (en) 1991-02-28
EP0500851A1 (en) 1992-09-02
CS261791A3 (en) 1992-03-18
SK278919B6 (sk) 1998-04-08
ATE119388T1 (de) 1995-03-15
KR0177493B1 (ko) 1999-03-20
NO921569D0 (no) 1992-04-23
DE69108007D1 (de) 1995-04-13
US5322698A (en) 1994-06-21
KR927002214A (ko) 1992-09-03
CA2067733A1 (en) 1992-02-25
FI103015B1 (fi) 1999-04-15
IN171740B (fi) 1992-12-26
EP0500851B1 (en) 1995-03-08
CA2067733C (en) 2002-03-19
ES2072617T3 (es) 1995-07-16
FI103015B (fi) 1999-04-15
CZ281577B6 (cs) 1996-11-13
FI921809A (fi) 1992-04-23
NO303669B1 (no) 1998-08-17
PT98758A (pt) 1992-07-31
IL99237A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
FI921809A0 (fi) Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur.
ES2018113A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
HUP9701690A2 (hu) Gombaellenes hatású tetrahidrofuránszármazékok és az ezeket tartalmazó gyógyszerkészítmények
ES8301967A1 (es) Procedimiento de preparar compuestos carbostirilicos.
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
NO954952D0 (no) Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
EP0158102A3 (en) New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
DK0650475T3 (da) 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamider, fremstilling deraf og anvendelse deraf som 5-HT2-antagonister
NO176018C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive S-enantiomerer av substituerte 2-aminotetraliner
ES8200678A1 (es) Un procedimiento para la produccion de 10-(4-piperidinil)-10, 11-dihidro-dibenzo b,f 1,4 oxarepinas; tiazepinas y diaze-pinas.
ZA935045B (en) Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
GB1354451A (en) Halogen-substituted phenyl-alkylamines and their derivatives
MXPA02006250A (es) Derivados de butino diol.
JPS5278887A (en) Synthesis of n-(2-tetrahydrofuryl)-5-fluorouracil
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
GB1397497A (en) Herbicidal mixture
JPS57179108A (en) Cement composition for filling of dental root canal
JPS5231079A (en) Preparation of uracil derivatives
MX9710277A (es) Derivados de purina sustituidos, procedimientos para su preparacion, su utiliazacion y agentes que los contienen.
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: TEVA GYOGYSZERGYAR ZARTKOERUEEN MUEKOEDOE RESZVENY

Free format text: TEVA GYOGYSZERGYAR ZARTKOERUEEN MUEKOEDOE RESZVENYTARSASAG

MA Patent expired